McKesson | MCK - Ebitda

Aktienkurs
828.11
Täglich Wechseln
-7.99 -0.96%
Monatlich
-5.87%
Jährlich
19.15%
Q2 Prognose
810.39




Ebitda Veränderung Datum
Acadia Healthcare USD 99.85M 73.17M 2025-12
Align Technology USD 183.84M 19.77M 2025-09
Cardinal Health USD 981M 5M 2025-12
Centene USD -903M 1.02B 2025-12
Charles River Laboratories USD 258.06M 24.83M 2025-12
Cigna USD 2.86B 56M 2025-03
Community Health Systems USD 395M 19M 2025-12
Computer Programs Systems USD 19.2M 10.52M 2025-12
CVS Health USD 3.74B 349M 2025-12
DaVita Healthcare Partners USD 772.7M 89.45M 2025-12
Dentsply International USD 135M 32M 2025-12
Elevance Health USD 4.21B 2.02B 2026-03
Encompass Health USD 335.6M 35.5M 2025-12
HCA USD 3.8B 312M 2026-03
Henry Schein USD 291M 4M 2025-12
Humana USD -290M 1.11B 2025-12
IQVIA Holdings USD 1.05B 97M 2025-12
J&J USD 7.19B 2.32B 2025-12
Laboratory Of America USD 588.1M 24.1M 2025-12
McKesson USD 1.68B 418M 2025-09
Molina Healthcare USD 267M 385M 2026-03
Owens Minor USD 90.02M 2.15M 2025-12
Quest Diagnostics USD 557M 20M 2026-03
Stryker USD 1.67B 206M 2025-09
Tenet Healthcare USD 1.18B 84M 2025-12
UnitedHealth USD 9.99B 8.5B 2026-03
Universal Health Services USD 678.67M 8.07M 2025-12
Veradigm USD 38.81M 29.61M 2022-09